Latest News about AMGN
Recent news which mentions AMGN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 26, 2024
From Benzinga
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
November 26, 2024
From Benzinga
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
November 26, 2024
From Benzinga
Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau
November 26, 2024
From Benzinga
Investing in Pharma Stocks? Check These 3 Things First
November 22, 2024
From Motley Fool
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
November 21, 2024
From Benzinga
Decoding Amgen's Options Activity: What's the Big Picture?
November 20, 2024
Tickers
AMGN
From Benzinga
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
November 19, 2024
From Benzinga
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
November 18, 2024
From Benzinga
Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone
November 18, 2024
From Benzinga
2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious
November 16, 2024
Tickers
AMGN
From Motley Fool
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever
November 15, 2024
From Motley Fool
2 Dividend Stocks to Buy Hand Over Fist in November
November 14, 2024
From Motley Fool
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
November 13, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
From Benzinga
Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop
November 12, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 12, 2024
From Benzinga
Investors Like Certainty. Trump's Win Gave Them Some.
November 08, 2024
From Motley Fool
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
November 08, 2024
From Benzinga
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
November 05, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 05, 2024
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
October 31, 2024
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
From Benzinga
Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday?
October 30, 2024
From Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
October 28, 2024
From Motley Fool
2 Reliable Dividend Stocks You Can Buy and Hold Forever
October 26, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.